Perceived Treatment Effectiveness, Medication Compliance, and Complementary and Alternative Medicine Use Among Veterans with Bipolar Disorder by Jarman, Christopher N. et al.
Perceived Treatment Effectiveness, Medication Compliance,
and Complementary and Alternative Medicine Use Among
Veterans with Bipolar Disorder
Christopher N. Jarman, M.S.W.,1 Brian E. Perron, Ph.D., L.C.S.W.,1
Amy M. Kilbourne, Ph.D., M.P.H.,2 and Carrie Farmer Teh, Ph.D.3
Abstract
Objectives: Recent research shows a high rate of complementary and alternative medicine (CAM) use among
persons with mental disorders, although correlates and patterns of CAM use are relatively unknown. This study
tested whether CAM use is associated with perceived effectiveness of conventional treatment (i.e., psychotropic
medication and psychotherapy) and medication compliance among persons with bipolar disorder.
Design: Patients with bipolar disorder (n¼ 435) were included as part of a naturalistic cohort study. Measures of
CAM utilization, medication compliance, and perceptions of the effectiveness of psychotropic medications and
psychotherapy were based on previously established questionnaires. Associations were tested using bivariate
and multivariate analyses.
Results: Bivariate analyses showed that patients who did not perceive psychotherapy as effective at improving
social, family, or job functioning reported greater CAM use. However, medication compliance was not signif-
icantly associated with use of CAM. Patients who used oral (e.g., herbal therapies) or cognitive (e.g., meditation)
CAM were more likely to report that their medications were not effective at relieving manic or depressive
symptoms. Users of cognitive CAM were more likely to report that their medications did not help with social,
job, or family functioning, and that they did not prevent recurrences of manic or depressive episodes. None of
the bivariate associations remained significant in multivariate analyses.
Conclusions: Prior research has suggested that persons who are dissatisfied with treatment for medical condi-
tions are more likely to use CAM therapies. However, the results of this study do not show CAM therapies to be
associated with perceived effectiveness of treatments for mental health problems among this sample of persons
with serious mental illnesses. This suggests that motivations for CAM use may vary by population and con-
dition. Because few correlates of CAM use among persons with serious mental illnesses are known, providers
should conduct routine assessments of CAM use.
Introduction
Complementary and alternative medicine (CAM) re-fers to a variety of diverse treatment practices that are not
considered conventional medicine. Complementary medicine
refers to therapies used in combination with conventional
therapies, while alternative medicine refers to therapies used
instead of conventional medicine.1 Although relatively little
research has examined the use of CAM among adults with
serious mental illnesses (SMI), interest in the topic is increas-
ing. Recent studies suggest that rates of CAM use among this
group are relatively high.2,3 For example, a recent survey
found that 22% of adults with mania or psychosis used some
form of CAM therapy.4
Although interest in CAM is growing, very little is known
about the patterns and correlates of use among persons with
serious mental illnesses. This is an important area of inves-
tigation, as clinicians need to be aware of potential interac-
tions with conventional treatments.5 Provider awareness of
their patient’s use of CAM therapies may be important to
ensuring that patient preferences are recognized to help en-
sure continued engagement in conventional treatment. In
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particular, it is important to understand how often and for
what reasons persons with SMI use CAM therapies. His-
torically, the quality of conventional treatment for persons
with SMI has been poor.6,7 Persistent distress due to symp-
toms of mental illness and perceived ineffectiveness of treat-
ment may motivate patients to seek relief through other
means, including CAM therapies.
Use of CAM therapies may also be associated with medi-
cation nonadherence. Recent pharmacologic agents still have
significant side-effects including weight gain, nausea, diar-
rhea, sedation, anxiety, and others,8 and nonadherence to
medications for mental disorders remains high. For example,
more than one third of patients with bipolar disorder have
reported rates of nonadherence as high as 60%.9,10 Persons
who are nonadherent may be more likely to experiment
with or regularly use CAM therapies to relieve symptoms,
especially if they feel that their overall treatment regimen
is ineffective. Complicating factors such as drug–drug in-
teractions, drug substitutions with CAM, and treatment
noncompliance demand a greater understanding of factors
associated with CAM use among persons with serious
mental illnesses.
This study tested whether CAM use was associated with
perceived effectiveness of conventional treatment and med-
ication compliance among a large sample of persons with
bipolar disorder. Bipolar disorder is an ideal sample for this
investigation due to the chronicity of the condition, public
burden,7 significant medication side-effects,11 and docu-
mented high rates of CAM use among this population.2,3,11
Materials and Methods
Participants
Participants were recruited from the Continuous Improve-
ment for Veterans in Care–Mood Disorders (CIVIC-MD)
study.12 Details about this study are available elsewhere.12
Briefly, the CIVIC-MD is a naturalistic cohort study of 435
veterans diagnosed with bipolar disorder recruited from
a large urban Veterans Affairs (VA) mental health facility
in the mid-Atlantic region. Data were collected from July
2004 to July 2006. Seventy-seven percent (77%) of subjects
(n¼ 336) were white, and 13% (n¼ 58) were black. Fourteen
percent (14%) of subjects (n¼ 62) were women. Average in-
comes were low. Sixty percent (60%) (n¼ 254) earned less
than $20,000 per year. The average age of subjects was 49
years (SD¼ 11), with a range of 21–78 years. Additional
details regarding the CIVIC-MD study are available else-
where.12
Inclusion criteria included a current diagnosis of bipo-
lar disorder (I, II, NOS), cyclothymia, or schizoaffective
disorder-bipolar subtype based upon chart review and
provider confirmation.
The study was reviewed and approved by the Veterans
Affairs Institutional Review Board. Seven hundred and twenty
(720) eligible veterans were approached for participation,
and 435 completed the self-administered survey. Exclusions
occurred for the following reasons: the patient refused to
participate (n¼ 148), the provider determined that the pa-
tient was not capable of providing consent (n¼ 104), or the
patient enrolled but did not complete the survey (n¼ 33).
The effective sample size for the current study after exclu-
sion of missing data was N¼ 429. Logistic regression was
used to examine patterns of missing data and none were
identified.
Measurement
Treatment effectiveness. Perceived effectiveness of psy-
chotropic medications and psychotherapy were assessed us-
ing items adapted from Meredith and colleagues.13 Questions
elicited veterans’ thoughts about whether medications and
psychotherapy relieved bipolar symptoms, improved func-
tioning, minimized side-effects, and prevented symptomatic
relapse. Four (4) items measured perceived effectiveness of
medications, and four parallel items measured effectiveness
of psychotherapy. Responses ranged from 0 (‘‘very unlikely’’)
to 4 (‘‘very likely’’).
Medication compliance. Medication compliance was as-
sessed using the validated Morisky scale,14 a four-item yes=
no instrument frequently used for assessing patient adher-
ence to treatment across a variety of chronic medical and
psychiatric conditions, including affective disorders.15,16 The
Morisky scale includes items querying whether the patient
ever forgot to take medications, was careless with medica-
tions, at times stopped taking medications when feeling
better, or stopped taking medications when feeling worse.
The four items were summed, with higher scores reflecting
greater levels of compliance. Recent research has shown this
scale to have good reliability (a¼ .83), and concurrent and
predictive validity in outpatient settings.14,17
CAM utilization. CAM utilization was based on a previ-
ously established questionnaire by Kessler et al.18 This sur-
vey was selected because it included a wide range of CAM
therapies observed in patients with bipolar disorder in prior
studies, in addition to the broader population.4 Participants
were asked whether they used any of 14 therapies within
the past year (yes=no). Four (4) categories of CAM thera-
pies were considered based on previously established defi-
nitions by Kessler et al.16: physical, oral medications, cognitive,
and dietary. Physical CAM included use of acupuncture=
acupressure, chiropractic, or massage therapies. Oral-based
CAM included herbal medications, homeopathy, St. John’s
Wort, or vitamins=minerals. Cognitive-based CAM included
relaxation=breathing exercises, imagery, or meditation. Diet-
oriented CAM included dietary=weight loss supplements or
any special dietary modifications. Spirituality and self-help
practices were among the 14 therapies assessed. Because they
are widely recognized as a standard of care among popula-
tions seeking treatment for SMI, they were not included in
this study of CAM.
Sociodemographics. Sociodemographic variables were
examined in this study were age, gender, marital status,
education, and employment status.
Statistical analysis. Data were summarized using de-
scriptive statistics. Associations between CAM use and per-
ceived effectiveness of conventional therapies and medication
adherence were examined using t tests. Statistically signifi-
cant bivariate associations were tested using multivariate
linear regression models, which controlled for potentially
confounding sociodemographic characteristics. Statistically
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significant bivariate associations were examined with linear
regression models, controlling for potentially confounding
sociodemographic characteristics. Sociodemographic vari-
ables included marital status, gender, employment status,
age, and education level. In analyzing statistically significant
associations, we used logistic regression for categorical data
and multivariate linear regression elsewhere. While not
mutually exclusive, CAM categories were analyzed inde-
pendently. Thus, it is possible that participants used more
than one form of CAM.
Results
Perceived effectiveness of medications
Table 1 provides a summary of bivariate associations be-
tween CAM use and perceived effectiveness of treatment.
Patients who used oral or cognitive CAM were more likely to
indicate that their medications were not effective at relieving
manic or depressive symptoms (t[424.6]¼ 0.65, p¼ 0.034;
t[419.2]¼ 2.39, p¼ 0.017, respectively). Users of cognitive
CAM were also more likely to report that their medications
did not help with social, job, or family functioning
(t[412.6]¼ 2.10, p¼ 0.036), and that their medications did
not prevent recurrences of manic or depressive episodes
(t[423.6]¼ 2.16, p¼ 0.031). Users of physical and diet CAM
therapies did not exhibit differences in their perceived ef-
fectiveness of medications. The multivariate linear regression
models that tested the association between CAM use (i.e.,
oral and cognitive) and perceived effectiveness of medica-
tions while controlling for sociodemographic factors was
nonsignificant ( p> 0.05).
Perceived effectiveness of psychotherapy
Regarding perceived effectiveness of psychotherapy, only
one significant association was observed. Patients who used
cognitive CAM were more likely to report that psychother-
apy was not effective at improving social, family, or job
functioning (t¼ 2.265, df¼ 412.3, p¼ 0.024). The multivariate
linear regression model that tested the association between
cognitive CAM use and perceived effectiveness of psycho-
therapy was nonsignificant ( p> 0.05).
Medication adherence
Medication adherence was not associated with any type of
CAM use ( p> 0.05). Associations were tested using indi-
vidual items of the Morisky scale and the overall scale score.
Discussion
Although many patients use CAM therapies for mental
disorders, including SMI, very little is known about factors
associated with use of CAM. To our knowledge, this is the
first study to examine CAM use and its associations with
perceived effectiveness of conventional treatment and med-
ication compliance. Overall, we found some evidence that
persons who used CAM were slightly more likely to report
that their medications were ineffective. Use of oral and
cognitive CAM modestly predicted perceptions that medi-
cations did not relieve mania or depression. Cognitive CAM
uniquely predicted perceptions that medications did not re-
lieve social difficulties or prevent relapses of mania or de-
pression. However, these associations were of a small effect
size and were not significant after controlling for other so-
ciodemographic factors.
These findings are not consistent with the broader litera-
ture on CAM use for general medical conditions, in partic-
ular, findings that suggest that use of CAM may be sought
because conventional treatments are not perceived as effec-
tive.18,19 Some potential explanations are offered for these
differential findings. One possibility is that participants in
this survey may be using CAM for additional symptoms
beyond their existing conventional treatment, which is con-
sidered generally effective. Subsequent research using qual-
itative methods to understand reasons for using CAM would
be helpful, as this would help clarify the range of motiva-
tions and belief structures about CAM. Qualitative methods
could also shed light on an important distinction, namely,
whether participants are using CAM therapies as a comple-
ment or alternative to conventional medicine, or both. In
addition, their rationales for incorporating specific therapies
could be explored.
Another potential explanation relates to the study design.
CAM was measured as a lifetime variable, while frequency
and timing of CAM use were not considered. Patients may
have experimented with various types of CAM therapies
over time, which would attenuate any real associations.
Additionally, a selection bias in this sample may be present.
That is, persons who find their treatment inadequate may
have dropped out prior to this study, and we are unaware of
CAM use within this group. Improvements in measurement
and sampling design will be necessary to advance this area
of research.
Finally, study participants may be using CAM to improve
overall health and not simply in response to specific symp-
toms that are targeted by psychotherapy or psychotropic
medications. Thus, patients may not consider these therapies
to be effective for specific symptom relief but rather for
general well-being that is not influenced by conventional
treatment. Indeed, prior research indicates that patients often
use many forms of CAM to improve well-being rather than
as a targeted treatment for specific symptoms.5
Strengths of this study include the large sample size and a
population actively seeking treatment for bipolar disorder.
The use of validated measures of medication compliance and
CAM use are also beneficial. Study findings should also be
considered in the context of the limitations. Most notably,
subjects in this study were recruited from a VA clinic that
serves patients with relatively severe symptoms. The sample
is over-represented by older men who tend to earn less and
have lower educational levels than subjects in representative
national samples. Thus, the findings may not generalize to
other clinic settings or the general population.
Conclusions
Overall, this study provides evidence that CAM use is not
associated with perceived effectiveness of treatment. Unlike
the general population of CAM users, the research to date
has not revealed any consistent patterns of CAM use among
persons with serious mental illnesses. Given the high rate of
CAM use among persons with SMI, it is important that
providers adopt a person-centered approach with respect to
CAM: that is, assessing for its use and respecting that CAM
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































may be an important part of the patient’s treatment prefer-
ences. Furthermore, disclosure of CAM use is low even
among adults with chronic conditions.20 Engaging in this
discussion is particularly important, given the potential for
drug interactions.5,21
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